clindamycin has been researched along with Heart Septal Defects, Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asari, S; Fukuyama, M; Hata, A; Hata, D; Iki, Y; Watanabe, K; Yoshioka, T | 1 |
Grajek, S; Ozorowski, T; Straburzyńska-Migaj, E; Trojnarska, O; Łanocha, M | 1 |
2 other study(ies) available for clindamycin and Heart Septal Defects, Ventricular
Article | Year |
---|---|
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Bacteremia; Clindamycin; Conservative Treatment; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Heart Septal Defects, Ventricular; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Artery; Radiography; Rifampin; Staphylococcal Infections; Sulfamethizole; Trimethoprim | 2019 |
[Effective treatment of recurrent infective endocarditis. Is it always in compliance with the guidelines?].
Topics: Adult; Aminoglycosides; Aortic Valve; Clindamycin; Endocarditis, Bacterial; Gentamicins; Guideline Adherence; Heart Septal Defects, Ventricular; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Peptides; Recurrence; Staphylococcal Infections; Vancomycin | 2010 |